Bardin Hill Management Partners’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bardin Hill Management Partners’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-219,997	Closed	-$7.44M	–	115
2021 Q2	$7.44M	Buy	+219,997	New	+$5.61M	1.31%	27

Bardin Hill Management Partners's CNST Position: Q3 2021 in Review

Bardin Hill Management Partners sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 219,997 shares — an estimated $7.44M sold.

Bardin Hill Management Partners first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $7.44M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Bardin Hill Management Partners reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Bardin Hill Management Partners sold 219,997 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $7.44M.
Bardin Hill Management Partners first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Bardin Hill Management Partners's Constellation Pharmaceuticals, Inc. position peaked at $7.44M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Bardin Hill Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.